Dosage Adjustment for Ceftazidime in Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic Modeling

Ceftaroline Dosage Optimized for Pediatric Patients with Renal Impairment Using Physiologically Based Pharmacokinetic Modeling

The Journal of Clinical Pharmacology ◽

10.1002/jcph.1944 ◽

2021 ◽

Author(s):

Jie Zhou ◽

Xiang You ◽

Guimu Guo ◽

Meng Ke ◽

Jianwen Xu ◽

...

Keyword(s):

Renal Impairment ◽

Pediatric Patients ◽

Physiologically Based Pharmacokinetic Modeling and Dose Adjustment of Teicoplanin in Pediatric Patients with Renal Impairment

The Journal of Clinical Pharmacology ◽

10.1002/jcph.2000 ◽

2021 ◽

Author(s):

Jianwen Xu ◽

Rongfang Lin ◽

Yong Chen ◽

Xiang You ◽

Pinfang Huang ◽

...

Keyword(s):

Renal Impairment ◽

Dose Adjustment ◽

Pediatric Patients ◽

Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients

Archives of Pharmacal Research ◽

10.1007/s12272-021-01363-1 ◽

2021 ◽

Author(s):

Eui Hyun Jung ◽

Chang-Keun Cho ◽

Pureum Kang ◽

Hye-Jung Park ◽

Yun Jeong Lee ◽

...

Keyword(s):

Genetic Polymorphism ◽

Pediatric Patients ◽

Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients

Journal of Pharmaceutical Sciences ◽

10.1016/j.xphs.2019.01.028 ◽

2019 ◽

Vol 108 (6) ◽

pp. 2191-2198 ◽

Cited By ~ 8

Author(s):

Tycho Heimbach ◽

Wen Lin ◽

Florence Hourcade-Potelleret ◽

Xianbin Tian ◽

Francois Pierre Combes ◽

...

Keyword(s):

Pediatric Patients ◽

Dose Selection ◽

Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12456 ◽

2019 ◽

Vol 8 (11) ◽

pp. 835-844 ◽

Cited By ~ 8

Author(s):

Paul R. V. Malik ◽

Andrea N. Edginton

Keyword(s):

Allometric Scaling ◽

Pediatric Patients ◽

Physiologically‐Based Pharmacokinetic Modeling of Remdesivir and its Metabolites to Support Dose Selection for the Treatment of Pediatric Patients with COVID‐19

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2176 ◽

2021 ◽

Cited By ~ 1

Author(s):

Justin D. Lutz ◽

Anita Mathias ◽

Polina German ◽

Cheryl Pikora ◽

Sunila Reddy ◽

...

Keyword(s):

Pediatric Patients ◽

Dose Selection ◽

Physiologically Based ◽

Selection For

Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment

European Journal of Clinical Pharmacology ◽

10.1007/s00228-020-03072-y ◽

2021 ◽

Author(s):

Wanhong Wu ◽

Meng Ke ◽

Lingling Ye ◽

Cuihong Lin

Keyword(s):

Renal Impairment ◽

Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulation

Biopharmaceutics & Drug Disposition ◽

10.1002/bdd.1919 ◽

2014 ◽

Vol 35 (9) ◽

pp. 543-552 ◽

Cited By ~ 19

Author(s):

Chuang Lu ◽

Ajit Suri ◽

Wen Chyi Shyu ◽

Shimoga Prakash

Keyword(s):

Cytochrome P450 ◽

Drug Interaction ◽

Renal Impairment ◽

Modeling And Simulation ◽

Interaction Potential ◽

Physiologically Based ◽

Drug Drug Interaction

Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12382 ◽

2019 ◽

Vol 8 (2) ◽

pp. 118-126 ◽

Cited By ~ 5

Author(s):

Kosuke Doki ◽

Sibylle Neuhoff ◽

Amin Rostami-Hodjegan ◽

Masato Homma

Keyword(s):

Renal Impairment ◽

Drug Interactions ◽

Dabigatran Etexilate ◽

Potential Drug ◽

P Glycoprotein ◽

Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination

Clinical Pharmacokinetics ◽

10.1007/s40262-020-00969-w ◽

2020 ◽

Author(s):

Lei Sun ◽

Lisa von Moltke ◽

Karen Rowland Yeo

Keyword(s):

Renal Impairment ◽